Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1979 Feb;15(2):318–322. doi: 10.1128/aac.15.2.318

BL-S786 (Ceforanide), a New Parenteral Cephalosporin: In Vitro Studies

Susanne S Weaver 1, Barbara M LeBlanc 1, Gerald P Bodey 1
PMCID: PMC352652  PMID: 426520

Abstract

BL-S786 (ceforanide) is a new cephalosporin which showed broad-spectrum activity in vitro against 453 clinical isolates. At a concentration of 3.12 μg/ml, it inhibited greater than 75% of isolates of Escherichia coli, Klebsiella spp., Proteus mirabilis, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae. Essentially no activity was observed against isolates of Serratia marcescens, and only minimal activity was observed against Enterobacter spp. Its activity was directly related to the size of the inoculum. The minimal bactericidal concentrations were similar to the minimal inhibitory concentrations for isolates of all organisms except S. aureus and S. pyogenes. The minimal bactericidal concentrations were considerably higher than the minimal inhibitory concentrations for these organisms.

Full text

PDF
318

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aswapokee N., Aswapokee P., Fu K. P., Neu H. C. In vitro activity and beta-lactamase stability of BL-S786 compared with those of other cephalosporins. Antimicrob Agents Chemother. 1978 Jul;14(1):1–5. doi: 10.1128/aac.14.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bodey G. P., Weaver S. In vitro studies of cefamandole. Antimicrob Agents Chemother. 1976 Mar;9(3):452–457. doi: 10.1128/aac.9.3.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Jones R. N., Fuchs P. C., Gavan T. L., Gerlach E. H., Barry A., Thornsberry C. BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolates. J Antibiot (Tokyo) 1977 Jul;30(7):576–582. doi: 10.7164/antibiotics.30.576. [DOI] [PubMed] [Google Scholar]
  4. Jones R. N., Thornsberry C., Barry A. L., Fuchs P. C., Gavin T. L., Gerlach E. H. BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporins. J Antibiot (Tokyo) 1977 Jul;30(7):583–592. doi: 10.7164/antibiotics.30.583. [DOI] [PubMed] [Google Scholar]
  5. Leitner F., Misiek M., Pursiano T. A., Buck R. E., Chisholm D. R., DeRegis R. G., Tsai Y. H., Price K. E. Laboratory evaluation of BL-S786, a cephalosporin with broad-spectrum antibacterial activity. Antimicrob Agents Chemother. 1976 Sep;10(3):426–435. doi: 10.1128/aac.10.3.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Shadomy S., Wagner G., Carver M. In vitro and in vivo studies with BL-S786, cefoxitin, and cefamandole. Antimicrob Agents Chemother. 1978 Mar;13(3):412–415. doi: 10.1128/aac.13.3.412. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES